×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
TLR2 and TLR3 expression as a biomarker for the risk of doxorubicin-induced heart failure.
29959987
2018
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
TLR2 and TLR3 expression as a biomarker for the risk of doxorubicin-induced heart failure.
29959987
2018
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.
24535859
2014
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.
24535859
2014
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
Serum BNP levels and BNP protein and mRNA expression in the carvedilol-treated RHF group were significantly reduced when compared with the RHF 2 group (p<0.05).
19650993
2009
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
Serum BNP levels and BNP protein and mRNA expression in the carvedilol-treated RHF group were significantly reduced when compared with the RHF 2 group (p<0.05).
19650993
2009
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
16777915
2006
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).
16762801
2006
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).
16762801
2006
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
16777915
2006
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors.
16101196
2005
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
16360360
2005
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
16360360
2005
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors.
16101196
2005
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
Nesiritide: past, present, and future.
16333235
2005
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.
15860969
2005
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.
15860969
2005
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
Nesiritide: past, present, and future.
16333235
2005
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
Carvedilol modulates the expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in a rat model of volume-overload heart failure.
15732037
2005
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
Carvedilol modulates the expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in a rat model of volume-overload heart failure.
15732037
2005
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).
12628948
2003
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).
12628948
2003
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Therapeutic
disease
CTD_human
Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure.
11136700
2001
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure.
11136700
2001
×
Entrez Id:
4879
Gene Symbol:
NPPB
NPPB
0.300
Biomarker
disease
CTD_human
Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity.
11279304
2000